Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets

Journal of the American Chemical Society

Volumn 130, Issue 29, 2008, Pages 9186-9187

  Pan, Dipanjan ^a   Caruthers, Shelton D ^a,b   Hu, Grace ^a   Senpan, Angana ^a   Scott, Mike J ^a   Gaffney, Patrick J ^c   Wickline, Samuel A ^a   Lanza, Gregory M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPS HEALTHCARE   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CALCIUM; CARBOXYLIC ACID; CHELATE; CONTRAST MEDIUM; FIBRIN; LANTHANIDE; LIGAND; LINOLEIC ACID; MANGAFODIPIR; MANGANESE; MANGANESE SULFATE; NANOPARTICLE; POLYETHYLENEIMINE;

ALKALINITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; DRUG TARGETING; FIBRIN CLOT; FIBROSIS; LIVER CELL; NANOCHEMISTRY; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; SYNTHESIS; TARGET ORGAN; TRANSMISSION ELECTRON MICROSCOPY;

BIOTIN; CAMPTOTHECIN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FIBRIN; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MANGANESE; MICELLES; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; ORGANOMETALLIC COMPOUNDS;

EID: 47749138981     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja801482d     Document Type: Article

References (29)

1. (a) Winter, P. M.; Caruthers, S. D.; Wickline, S. A.; Lanza, G. M. Nanofabrication towards Biomedical Applications 2005, 227-49.
2. (b) Caruthers, S. D.; Wickline, S. A.; Lanza, G. M. Curr. Opin. Biotechnol. 2007, 18, 26-30.
3. (c) Weissleder, R.; Kelly, K.; Sun, E. Y.; Shtatland, T.; Josephson, L. Nat. Biotechnol. 2005, 23, 1418.
4. (d) Won, J.; Kim, M.; Yi, Y.-W.; Kim, Y. H.; Jung, N.; Kim, T. K. Science 2005, 309, 121.
5. (e) Brown, M. A.; Semelka, R. C. MRI: Basic Principles and Applications, Wiley-Liss, New York, 2003.
6. (f) Artemov, D. J. Cellular Biochem. 2003, 90, 518-24.
7. (g) Hawker, C. J.; Wooley, K. L. Science 2005, 309, 1200-5.
8. (h) O'Reilly, R. K.; Hawker, C. J.; Wooley, K. L. Chem. Soc. Rev. 2006, 35, 1068-83.
9. (i) Whitesides, G. M. Small 2005, 1, 172-9.
10. (j) Hummel, H.; Weiler, V. U.; Hoffmann, R. PCT Int. Appl. WO2006064451A2, 2006.
11. (k) Unger, E. C.; Fritz, T. A.; Gertz, E. W. U.S. Pat. US6139819.
12. (l) Nishiyama, N.; Kataoka, K. Pharmacol. Ther. 2006, 11, 630.
13. (m) Wickline, S. A.; Lanza, G. M. J. Cell. Biochem. 2002, (Suppl. 39), 90-7.
14. (n) Winter, P. M.; Morawski, A. M.; Caruthers, S. D.; Fuhrhop, R. W.; Zhang, H.; Williams, T. A.; Allen, J. S.; Robertson, J. D.; Lanza, G. M.; Wickline, S. A. Circulation 2003, 108, 2270-4.
15. (o) Turner, J. L.; Pan, D.; Plummer, R.; Chen, Z.; Whittaker, A. K.; Wooley, K. L. Adv. Funct. Mater. 2005, 15, 1248.
16. (a) Kuo, P. H. J. Am. Coll. Radiol. 2008, 5, 29-35.
17. (b) Abu-Alfa, A. K. J. Am. Coll. Radiol. 2008, 5, 45-52.
18. (c) Ersoy, H.; Rybicki, F. J. J. Magn. Reson. Imaging 2007, 26 (5), 1190-7.
19. (a) Na, H. B.; Lee, J. H. Angew. Chem., Int. Ed. 2007, 46, 5397-401.
20. (b) Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Chem. Rev. 1999, 99, 2293.
21. (c) Ponce, A. M. J. Natl. Cancer Inst. 2007, 99, 53-63.
22. (d) Schwendener, R. A. Int. J. Pharm. 1989, 3, 249-59.
23. (a) Lauterbur, P. C.; Dias, M. H. M.; Rudin, A. M. In Frontiers of Biological Energetics, Dutton, P. L.; Leigh, J. S.; Scarpa, A., Eds.; Academic Press: New York, 1978, 752-9.
24. (b) Mendonca-Dias, M. H.; Gaggelli, E.; Lauterbur, P. C. Sem. Nucl. Med. 1983, 13, 364-76.
25. (c) Wendland, M. F. NMR Biomed. 2004, 17, 581-594.
26. (a) Chechik, V.; Zhao, M.; Crooks, R. M. J. Am. Chem. Soc. 1999, 121, 4910-1.
27. (b) Chen, Y. Macromolecules 2005, 38, 227-9.
28. Look, D.C.; Locker, D. R. Rev. Sci. Instrum. 1970, 41, 621-7.
29. Raut, S.; Gaffney, P. J. Throm. Haemostasos 1996, 76, 56-64.